New insights into the biology of multiple myeloma using a combination of May-Grünwald-Giemsa staining and fluorescence in situ hybridization techniques at the single cell level

Annals of Hematology

Volumn 80, Issue 11, 2001, Pages 662-668

  Nickenig, C ^a   Lang, N K ^a   Schoch, C ^a   Hiddemann, W ^a   Haferlach, T ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

Cell lineage involvement; Chromosomal aberration; Fluorescence immunophenotyping and in situ hybridization (FICTION); May Grunwald Giemsa (MGG) and fluorescence in situ hybridization (FISH); Multiple myeloma

Indexed keywords

CD34 ANTIGEN; DYE; EOSIN; EOSINE YELLOWISH (YS); MAY GRUNWALD GIEMSA; MAY-GRUNWALD GIEMSA; METHYLENE BLUE;

ADULT; AGED; ARTICLE; BONE MARROW CELL; CASE REPORT; CELL LINEAGE; CELL NUCLEUS; CELL TRANSFORMATION; CHEMISTRY; CHROMOSOME ABERRATION; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENETICS; HUMAN; IMMUNOPHENOTYPING; MALE; METHODOLOGY; MULTIPLE MYELOMA; PLASMA CELL; STAINING; TRISOMY; ULTRASTRUCTURE;

ADULT; AGED; ANTIGENS, CD34; BONE MARROW CELLS; CASE REPORT; CELL LINEAGE; CELL NUCLEUS; CELL TRANSFORMATION, NEOPLASTIC; CHROMOSOME ABERRATIONS; DYES; EOSINE YELLOWISH-(YS); FEMALE; HUMAN; IMMUNOPHENOTYPING; IN SITU HYBRIDIZATION, FLUORESCENCE; MALE; METHYLENE BLUE; MIDDLE AGE; MULTIPLE MYELOMA; PLASMA CELLS; STAINING AND LABELING; TRISOMY;

EID: 0035513004     PISSN: 09395555     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002770100366     Document Type: Article

References (28)

1. Bakkus M, Van Riet I, de Greef C, Van Camp B, Thielemans K (1995) The clonogenic precursor cell in multiple myeloma. Leuk Lymphoma 18:221-229
2. Barlogie B, Epstein J, Selvanayagam P, Alexanian R (1989) Plasma cell myeloma: new biological insights and advances in therapy. Blood 73:865-879
3. Calasanz MJ, Cigudosa JC, Odero MD, et al. (1996) Hypodiploidy and 22q11 rearrangements are associated with poor prognosis in patients with multiple myeloma (MM): 7-years of follow up (abstract). Blood 88 [Suppl 1]:390a
4. Cordell JL, Falini B, Erber WN (1984) Immunoenzymatic labelling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP) complexes. J Histochem Cytochem 32: 219-229
5. Dewald GW, Kyle RA, Hicks GA, Greipp PR (1993) The clinical significance of cytogenetic studies in 100 patients with multiple myeloma, plasma cell leukemia, or amyloidosis. Eur J Cancer 29A:1269-1273
6. Drach J, Schuster J, Nowotny H, Angerler J, Rosenthal F, Fiegl M, Geissler K, Ludwig H (1995) Multiple myeloma: high incidence of chromosomal aneuploidy as detected by interphase fluorescence in situ hybridization. Cancer Res 55: 3854-3859
7. Drach J, Angerler J, Schuster J, Rothermundt C, Thalhammer R, Haas OA, Jager U, Fiegl M, Geissler K, Ludwig H, Huber H (1995) Interphase fluorescence in situ hybridization identifies chromosomal abnormalities in plasma cells from patients with monoclonal gammopathy of undetermined significance. Blood 86:3915-3921
8. Durie BGM, Salmon SE (1975) A clinical staging system for multiple myeloma. Cancer 36:842-854
9. Durie BGM (1988) Plasma cell disorders: recent advances in the biology and treatment. In: Hoffbrand AV (ed) Recent advances in hematology, vol 5. Churchill Livingstone, London, pp 305-327
10. Epstein J (1992) Myeloma phenotype: clues to disease origin and manifestation. Hematol Oncol Clin North Am 6: 249-256
11. Erber WN, Pinching AJ, Mason DY (1984) Immunocytochemical detection of T and B cell population in routine blood smears. Lancet 1:1042-1046
12. Facon T, Lai JL, Nataf E, Preudhomme C, Zandecki M, Hammad M, Wattel E, Jouet JP, Bauters F (1993) Improved cytogenetic analysis of bone marrow plasma cells after cytokine stimulation in multiple myeloma: a report on 46 patients. Br J Haematol 84:743-745
13. Fialkow P.J., Jacobson R.J., Papayannopoulou T (1977) Chronic myelocytic leukemia: clonal origin in a stem cell common to granulocyte, erythrocyte, platelet and monocyte/ macrophage. Am J Med 63:125-130
14. Flactif M, Zandecki M, Lai JL, Bernardi F, Obein V, Bauters F, Facon T (1995) Interphase fluorescence in situ hybridization (FISH) as a powerful tool for the detection of aneuploidy in multiple myloma. Leukemia 9:2109-2114
15. Gould J, Alexanian R, Goodacre A, Pathak S, Hecht B, Barlogie B (1988) Plasma cell karyotype in multiple myeloma. Blood 71(2):453-456
16. Haferlach T, Winkemann M, Löffler H, Schoch R, Gassmann W, Fonatsch C, Schoch C, Poetsch M, Weber-Matthiesen K, Schlegelberger B (1996) The abnormal eosinophils are part of the leukemic cell population in AML M4Eo and carry the pericentric inversion 16: a combination of May-Grünwald-Giemsa staining and fluorescence in situ hybridization. Blood 87:2459-2463
17. Haferlach T, Winkemann M, Nickenig C, Meeder M, Ramm-Petersen L, Schoch R, Nickelsen M, Weber-Matthiesen K, Schlegelberger B, Schoch C, Gassmann W, Helmut Löffler (1997) Which compartments are involved in Philadelphia-chromosome positive chronic myeloid leukaemia? An answer at the single cell level by combining May-Grünwald-Giemsa staining and fluorescence in situ hybridization techniques. Br J Haematol 97:99-106
18. Hallek M, Bergsagel PL, Anderson KC (1998) Multiple myeloma: increasing evidence for a multistep transformation process. Blood 91:3-21
19. Heug-Ling Ng M, Kan A, Chung KW, Wong IH, Lo KW, Wickham NW, Lei KL, Lee JC (1999) Combined morphological and interphase fluorescence in situ hybridization study in multiple myeloma of Chinese patients. Am J Pathol 154:15-22
20. Lai JL, Zandecki M, Mary JY, Bernarde F, Izydorczyk V, Flactif M, Morel P, Jouet JP, Bauters F, Facon T (1995) Improved cytogenetics in multiple myeloma: a study of 151 patients including 117 patients at diagnosis. Blood 85:2490-2497
21. Löffler H (1991) Zytochemische Methoden. In: Huber H, Löffler H, Faber V (eds) Methoden der diagnostischen Hämatologie. Springer, Berlin Heidelberg New York
22. Rao PH, Cigudosa JC, Ning Y, Calasanz MJ, Iida S, Tagawa S, Michaeli J, Klein B, Dalla-Favera R, Jhanwar SC, Ried T, Chaganti RS (1998) Multicolor spectral karyotyping identifies new recurring breakpoints and translocations in multiple myeloma. Blood 92:1743-1748
23. Sawyer JR, Lukacs JL, Munshi N, Desikan KR, Singhal S, Mehta J, Siegel D, Shaughnessy J, Barlogie (1998) Identification of new nonrandom translocations in multiple myeloma with multicolor spectral karyotyping. Blood 92:4269-4278
24. Smadja NV, Louvet C, Isnard F, Dutel JL, Grange MJ, Varette C, Krulik M (1995) Cytogenetic study in multiple myeloma at diagnosis: comparison of two techniques. Br J Haematol 90: 619-624
25. Tabernero D, San Miguel JF, Garcia-Sanz R, Najero L, Garcia-Isidoro M, Perez-Simon JA, Gonzalez M, Wiegant J, Raap AK, Orfao A (1996) Incidence of chromosome numerical changes in multiple myeloma: fluorescence in situ hybridization analysis using 15 chromosome-specific probes. Am J Pathol 149:153-161
26. Weber-Matthiesen K, Deerberg J, Müller-Hermelink A, Schlegelberger B, Grote W (1993) Rapid immunophenotypic characterization of chromosomally aberrant cells by the new FICTION method. Cytogenet Cell Genet 63:122-125
27. + Hodgkin and Reed-Sternberg cells in 100% of analyzed cases of Hodgkin's disease. Blood 86:1464-1468
28. Weh HJ, Gutensohn K, Selbach J, Kruse R. Wacker-Backhaus G, Seeger D, Fiedler W, Fett W, Hossfeld DK (1993) Karyotype in multiple myeloma and plasma cell leukaemia. Eur J Cancer 29A (9):1269-1273